Bionyra, a biotechnology company building new biologics to treat immune diseases, emerged from stealth Monday with $165 million.
The biotech landscape witnessed a significant entry this week as Bionyra, a meticulously incubated biotechnology...
Knowledge and News for the Global Fight Against Cancer.
The biotech landscape witnessed a significant entry this week as Bionyra, a meticulously incubated biotechnology...
In a world increasingly accustomed to the extraordinary, Sharon Belvin and Jenney Bitner find profound...
The dynamic biopharmaceutical sector witnessed a series of significant developments this week, reflecting ongoing shifts...
The landscape of pediatric oncology is often defined by statistics, clinical trials, and medical breakthroughs,...
San Antonio, Texas – From May 16 to May 22, 2026, the La Cantera Resort...
The intersection of pre-existing genetic conditions and sudden-onset life-threatening illness presents a complex challenge for...
Shanghai, China – June 3, 2026 – Legend Biotech, a prominent biopharmaceutical company, has announced...
From May 16 to May 22, 2026, the La Cantera Resort in San Antonio, Texas,...
Medical researchers in the Twin Cities have launched a pioneering clinical trial that represents the...
The United States healthcare system is currently grappling with a burgeoning crisis in pediatric subspecialties,...